Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: a RANO review

T Kaley, I Barani, M Chamberlain, M McDermott… - Neuro …, 2014 - academic.oup.com
Background The outcomes of patients with surgery-and radiation-refractory meningiomas
treated with medical therapies are poorly defined. Published reports are limited by small …

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

L Rogers, I Barani, M Chamberlain, TJ Kaley… - Journal of …, 2015 - thejns.org
Evolving interest in meningioma, the most common primary brain tumor, has refined
contemporary management of these tumors. Problematic, however, is the paucity of …

Emerging systemic treatment options in meningioma

MJ Mair, AS Berghoff, PK Brastianos… - Journal of Neuro …, 2023 - Springer
Purpose Meningiomas are the most frequently diagnosed intracranial neoplasms. Usually,
they are treated by surgical resection in curative intent. Radiotherapy and stereotactic …

Current treatment options for meningioma

C Apra, M Peyre, M Kalamarides - Expert review of …, 2018 - Taylor & Francis
Introduction: With an annual incidence of 5/100,000, meningioma is the most frequent
primary tumor of the central nervous system. Risk factors are radiotherapy and hormone …

EANO guideline on the diagnosis and management of meningiomas

R Goldbrunner, P Stavrinou, MD Jenkinson… - Neuro …, 2021 - academic.oup.com
Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …

An overview of managements in meningiomas

L Zhao, W Zhao, Y Hou, C Wen, J Wang, P Wu… - Frontiers in …, 2020 - frontiersin.org
Meningioma is the most frequent primary tumor of the central nervous system. Important
advances have been achieved in the treatment of meningioma in recent decades. Although …

Meningiomas: updating basic science, management, and outcome

KJ Drummond, JJ Zhu, PML Black - The neurologist, 2004 - journals.lww.com
Background: Meningiomas are biologically complex and clinically and surgically
challenging. These features, combined with the rewarding potential for cure, make them of …

Advances in multidisciplinary therapy for meningiomas

PK Brastianos, E Galanis, N Butowski, JW Chan… - Neuro …, 2019 - academic.oup.com
Surgery has long been established as the first-line treatment for the majority of symptomatic
and enlarging meningiomas, and evidence for its success is derived from retrospective case …

Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution

LA Rosenberg, RA Prayson, J Lee, C Reddy… - International Journal of …, 2009 - Elsevier
PURPOSE: To evaluate the outcomes for patients with Grade III meningiomas as defined by
the 2007 World Health Organization standards. METHODS AND MATERIALS: The slides …

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

RY Huang, WL Bi, M Weller, T Kaley, J Blakeley… - Neuro …, 2019 - academic.oup.com
No standard criteria exist for assessing response and progression in clinical trials involving
patients with meningioma, and there is no consensus on the optimal endpoints for trials …